Osaic Holdings
JSPR icon

Osaic Holdings’s Jasper Therapeutics JSPR Stock Holding History

Osaic Holdings’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
45,850
+5,000
+12% +$3.74K ﹤0.01% 6199
2026
Q1 		$35.8K Hold
40,850
– – ﹤0.01% 5455
2025
Q4 		$74.8K Sell
40,850
-837
-2% -$1.68K ﹤0.01% 4956
2025
Q3 		$99.7K Buy
41,687
+40,850
+4,881% +$124K ﹤0.01% 4785
2025
Q2 		$4.64K Hold
837
– – ﹤0.01% 6582
2025
Q1 		$3.6K Hold
837
– – ﹤0.01% 6349
2024
Q4 		$17.9K Hold
837
– – ﹤0.01% 5421
2024
Q3 		$15.7K Hold
837
– – ﹤0.01% 5520
2024
Q2 		$19K Buy
+837
New +$20.1K ﹤0.01% 5382

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's JSPR Position: Q2 2026 in Review

Osaic Holdings increased its Jasper Therapeutics (JSPR) stake by 12% in Q2 2026, buying an estimated $3.74K and bringing the position to 45,850 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6199.

Osaic Holdings first reported a position in JSPR in Q2 2024 and has held it in 9 quarters since. The position peaked at $99.7K in Q3 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Osaic Holdings held 45,850 shares of Jasper Therapeutics worth $19.3K as of Q2 2026.
  • Osaic Holdings bought 5,000 Jasper Therapeutics shares in Q2 2026, an estimated $3.74K.
  • Jasper Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6199 holding.
  • Osaic Holdings first reported a position in Jasper Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Osaic Holdings's Jasper Therapeutics position peaked at $99.7K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.